检索结果-南通市图书馆

Raltitrexed + irinotecan as second-line chemotherapy in elderly patients with advanced colorectal cancer

Modern Chemotherapy 2012年第2期1卷 5-10页

作者： Barbara Vandendriessche Filip Geurs Ingeborg Hilderson Medical Oncology Department REG ZH Sint Maria Halle Belgium regionaal ziekenhuis sint maria ziekenhuislaan HALLE Belgium ZH sint maria Brussel Belgium

Aims and Background: Irinotecan is a standard option for relapsed/refractory advanced colo- rectal cancer. Combination with raltitrexed and irinotecan at lower than MTD doses should preserve disease stabilisation while decreasing toxicity. Patients and Methods: From January 2004 to April 2009, we analyzed, retrospectively, our data on irinotecan + raltitrexed, fixed doses, as a second-line chemotherapy in elderly pa- tients (>70 years) with advanced colorectal can- cer after failure of oxaliplatin based chemothera- py twenty-three patients were evaluated. Iri- notecan 350 mg + raltitrexed 2.6 mg were given every 3 weeks. Tumo r measurements were ob- tained after every third course of therapy. Toxic- ity was assessed weekly using the National Cancer Institute Common Toxicity Criteria, ver- sion 2. Results: The median number of treatment courses received per patient was 4 (range, 1 - 8). All pa-tients were assessable for toxicity and 21 for response. The most frequently observed severetoxicities were diarrhea (grade 2, 13%) No cases of significant neutropenia occurred. Ob- jective partial responses were observed in 3 pa- tients (13%). An additional 10 patients (43%) had stable disease as their best response. To date, 12 patients have progressed with a median time- to-progression of 4.3 months and a median sur- vival of 8.3 months. Conclusions: A three weekly irinotecan + raltitrexed administration can indu- ce tumor control in elderly patients with advanc- ed colorectalcancer that has progressed during or shortly after oxaliplatin-based chemotherapy. The diarrhea by irinotecan, seems mitigated by coad-ministration of a smaller dose of

关键词： Colorectal Elderly Irinotecan Second-Line Unresectable

来源：

维普期刊数据库评论

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Implantable cardiac defibrillators in octogenarians

引用

Journal of Geriatric Cardiology 2023年第1期20卷 23-31页

作者： Maarten Pauwelyn Sebastian Ingelaere Ruben Hoffmann Johan Vijgen Georges H.Mairesse Ivan Blankoff Yves Vandekerckhove Jean-Benoit le Polain de Waroux Bert Vandenberk Rik Willems University Hospitals Leuven CardiologyLeuvenBelgium KU Leuven Department of Cardiovascular SciencesLeuvenBelgium UZA Department of CardiologyAntwerpBelgium Jessa ziekenhuis Department of CardiologyHasseltBelgium Cliniques du Sud Luxembourg Department of CardiologyArlonBelgium CHU Charleroi Department of CardiologyCharleroiBelgium AZ sint-Jan Department of CardiologyBruggeBelgium University of Calgary Libin Cardiovascular InstituteCalgaryCanada

OBJECTIVE Implantable cardiac defibrillators(ICD)implantation in the very elderly remains *** aimed to describe the experience and outcome of patients over 80 years old implanted with an ICD in *** Data were extracted from the national QERMID-ICD *** implantations performed in octogenarians between February 2010 and March 2019 were *** on baseline patient characteristics,type of prevention,device configuration and all-cause mortality were *** determine predictors of mortality,multivariable Cox proportional hazard regression modelling was *** Nationwide,704 primo ICD implantations were performed in octogenarians(median age 82,IQR 81-83 years;83% male and 45% secondary prevention).During a mean follow-up of 3.1±2.3 years,249(35%)patients died,of which 76(11%)within the first year after *** multivariable Cox regression analysis age(HR=1.15,P=0.004),oncological history(HR=2.43,P=0.027)and secondary prevention(HR=2.23,P=0.001)were independently associated with 1-year mortality.A better preserved left ventricular ejection fraction(LVEF)was associated with a better outcome(HR=0.97,P=0.002).Regarding overall mortality multivariable analysis withheld age,history of atrial fibrillation,centre volume and oncological history as significant *** LVEF was again protective(HR=0.99,P=0.008).CONCLUSIONS Primary ICD implantation in octogenarians is not often performed in *** this population,11%died within the first year after ICD *** age,oncological history,secondary prevention and a lower LVEF were associated with an increased one-year ***,low LVEF,atrial fibrillation,centre volume and oncological history were indicative of higher overall mortality.

关键词： prevention implantation protective

来源：

维普期刊数据库

同方期刊数据库评论

在线全文

学校读者我要写书评

暂无评论

欢迎您,

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案：

请选择收藏分类：

通借通还

欢迎您,

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

在线全文

在线全文

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：